99
Views
4
CrossRef citations to date
0
Altmetric
Original Research

A novel approach to cardiovascular disturbances in patients with schizophrenia spectrum disorders treated with long-acting injectable medication

, , , , , , , , , , & show all
Pages 349-355 | Published online: 25 Jan 2019

Figures & data

Table 1 Median duration of disease and duration of LAI treatment (months) depending on components of metabolic syndrome – cardiovascular risk factors

Table 2 Median duration of disease and duration of treatment with LAI (months) according to echocardiography parameters

Table 3 Comparison of echocardiographic parameters between olanzapine and risperidone (Mann–Whitney U test results)